Genistein and its analogue enhanced tissue plasminogen activator activity in hela s3

Pathophysiology of Haemostasis and Thrombosis

Volumn 36, Issue 6, 2007, Pages 298-304

  Yatagai, Chieko ^a,b   Singu, Tatsuya ^a   Maruyama, Masugi ^b   Sumi, Hiroyuki ^a  

^a KURASHIKI UNIVERSITY OF SCIENCE AND THE ARTS   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Endothelial cells; Estrogen; Genistein; Soybean; Tissue plasminogen activator

Indexed keywords

BIOCHANIN A; DAIDZEIN; ESTROGEN; GENISTEIN; GLYCITEIN; ISOFLAVONE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HELA CELL; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; UMBILICAL VEIN; ZYMOGRAPHY;

ENZYME ACTIVATION; FIBRINOLYSIS; GENISTEIN; HELA CELLS; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PLANT PREPARATIONS; SOYBEANS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL VEINS;

EID: 77952336700     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000296280     Document Type: Article

References (21)

1. Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, Loskutoff DJ, Saito H: Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol 2002;161:1805-1814.
2. Murakami Y, Ueshima H, Okamura T, Kadowaki T, Hozawa A, Kita Y, Hayakawa T, Okayama A, NIPPON DATA80 Research Group: Life expectancy among Japanese of different smoking status in Japan: NIPPON DATA80. J Epidemiol 2007;7:54-60.
3. Sumi H, Yatagai C: Fermented soybean compounds and disease prevention; in Sugano M (ed): Soy in Health and Disease Prevention. New York, Taylor & Francis, 2005, pp 251-278.
4. Waller EK, Schleuning WD: Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis. J Biol Chem 1985;260:6354-6360.
5. Arts J, Herr I, Lansink M, Angel P, Kooustra T: Cell-type-specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res 1997;25:311-317.
6. Kurzer MS: Phytoestrogen supplement use by women. J Nutr 2003;133:1983-1986.
7. Obata A: Beneficial effects of soybean isoflavones (in Japanese). New Food Industr 1999;41:1-6.
8. Yamamoto J, Ijiri Y, Murakami M, Miura M, Yamashita T, Hashimoto M, Oiwa K, Okuda T: Effects of isoflavone glucoside and aglycons on thrombogenicity as measured using apoE-/- LDLR-/- double knockout mice. Soy Protein Res 2002;5:108-116.
9. Crutchley DJ, Conanan LB, Maynard JR: Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-O-tetradecanoylphorbol-13- acetate. Cancer Res 1980;40:849-852.
10. Astrup T, Müllertz S: The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952;40:346-351.
11. Miyazaki K: Various electrophoresis methods using polyacrylamide gel; in Basic Test Methods for Protein and Enzymes (in Japanese). Tokyo, Nankodo, 1996, pp 325-423.
12. Granelli-Piperno A, Reich E: A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 1952;40:346-351.
13. Tissot JD, Schneider P, Hauert J, Ruegg M, Kruithof EK, Bachmann F: Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urok inase. J Clin Invest 1982;70:1320-1323.
14. Kumagai T, Nagata T, Kubo Y, Fukuchi Y, Ebina K, Yokota K: Effects of low density lipoprotein and oxidized low density lipoprotein on the cytotoxic activity of Asp-hemolysin to murine macrophages. J Pharm Soc Jpn 2001;121:277-281.
15. Dieval J, Nguyen G, Gross S, Delobel J, Kruithof EK: A lifelong bleeding disorder associated with a deficiency of plasminogen activator inhibitor type 1. Blood 1991;77:528-532.
16. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, vander Saag PT, van der Burg B, Gustaffson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-4263.
17. Martin PM, Horwitz KB, Ryan DS, McGuire WL: Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978;103:1860-1867.
18. White RWV, Hackman RM, Soares SE, Becheff LA, Li Y, Sun B: Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology 2004;63:259-263.
19. Ozasa K, Nakao M, Watanabe Y, Hayashi K, Miki T, Mikami K, Mori M, Sakauchi F, Washio M, Ito Y, Suzuki K, Wakai K, Tamakoshi A: Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 2004;95:65-71.
20. Wang H, Murphy P: Isoflavone content in commercial soybean foods. J Agric Food Chem 1994;42:1666-1673.
21. Urano T, Sumiyoshi K, Pietraszek MH: PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA. Thromb Haemost 1991;61:474-478.